Titan Pharmaceuticals, Inc.
TTNP
$3.70
-$0.09-2.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -16.71% | -16.94% | -33.56% | -8.89% | -16.50% |
| Total Receivables | 19.23% | 36.84% | -71.64% | -87.19% | -31.45% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -80.13% | -31.36% | -30.82% | 59.80% | -18.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -60.61% |
| Total Current Assets | -18.85% | -17.20% | -34.20% | -17.55% | -19.00% |
|
|
|||||
| Total Current Assets | -18.85% | -17.20% | -34.20% | -17.55% | -19.00% |
| Net Property, Plant & Equipment | -- | -- | -- | -48.53% | -32.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -18.85% | -17.20% | -34.55% | -17.81% | -19.13% |
|
|
|||||
| Total Accounts Payable | -45.55% | 4.21% | -4.04% | 6.61% | -14.50% |
| Total Accrued Expenses | -- | -- | -- | -70.13% | -34.30% |
| Short-term Debt | -- | -- | -- | -- | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -49.23% | -32.99% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -83.33% |
| Total Other Current Liabilities | -- | -- | -- | -- | -83.33% |
| Total Current Liabilities | 30.19% | 4.21% | -36.31% | -61.29% | -22.62% |
|
|
|||||
| Total Current Liabilities | 30.19% | 4.21% | -36.31% | -61.29% | -22.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.19% | 4.21% | -36.31% | -61.29% | -22.62% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.13% | 0.12% |
| Retained Earnings | -0.20% | -0.19% | -0.53% | -0.27% | -0.51% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -24.49% | -19.11% | -34.39% | -8.36% | -18.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -24.49% | -19.11% | -34.39% | -8.36% | -18.33% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -24.48% | -19.10% | -34.38% | -8.36% | -18.33% |
|
|
|||||